A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Cladding panels on three Plymouth tower blocks to be removed "as soon as possible" after tests show they have the worst fire safety rating.
An unsettled weekend in store for many.
Four Arab nations that cut ties with Qatar over its alleged support for Islamist groups have handed their neighbour a 13-point list.